These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 30991867)

  • 1. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with Enterprise: Evaluation of clinical and vascular outcome.
    Lee KY; Chen DY; Hsu HL; Chen CJ; Tseng YC
    Interv Neuroradiol; 2016 Apr; 22(2):187-95. PubMed ID: 26542728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.
    Li A; Ye Z; Zhou W; Qin C
    Interv Neuroradiol; 2023 Dec; 29(6):731-737. PubMed ID: 36259331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular treatment of symptomatic intracranial atherosclerotic stenosis with low profile visualized intraluminal support stent.
    Tang H; Lu Z; Zeng Z; Zuo Q; Li Q; Xu F; Huang Q; Liu J
    J Clin Neurosci; 2021 Aug; 90():256-261. PubMed ID: 34275559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent.
    Vajda Z; Schmid E; Güthe T; Klötzsch C; Lindner A; Niehaus L; Sperber W; Peters J; Arnold G; Bäzner H; Henkes H
    Neurosurgery; 2012 Jan; 70(1):91-101; discussion 101. PubMed ID: 21778921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A long-term follow-up results of Enterprise stent in treatment of severe symptomatic basilar artery atherosclerotic stenosis].
    Zhao Y; Jin M; Liu Q; Liu D; Chen J; Du B
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):372-6. PubMed ID: 27143187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients.
    Feng Z; Duan G; Zhang P; Chen L; Xu Y; Hong B; Zhao W; Liu J; Huang Q
    BMC Neurol; 2015 Oct; 15():187. PubMed ID: 26449986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Outcome of Angioplasty Using a Wingspan Stent, Post-Stent Balloon Dilation and Aggressive Restenosis Management for Intracranial Arterial Stenosis.
    Park SC; Cho SH; Kim MK; Kim JE; Jang WY; Lee MK; Jo KD; You SH
    Clin Neuroradiol; 2020 Mar; 30(1):159-169. PubMed ID: 31123775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transluminal angioplasty and stenting for severe stenosis of the intracranial extradural internal carotid artery causing transient ischemic attack or minor stroke.
    Ko JK; Choi CH; Cha SH; Choi BK; Cho WH; Kang TH; Sung SM; Cho HJ; Lee TH
    Interv Neuroradiol; 2015 Aug; 21(4):511-9. PubMed ID: 26063697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases.
    Zhang K; Li TX; Wang ZL; Gao BL; Gu JJ; Gao HL; Wang YF; Xia JC
    Sci Rep; 2021 May; 11(1):10479. PubMed ID: 34006896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.
    Kim JK; Ahn JY; Lee BH; Chung YS; Chung SS; Kim OJ; Kim WC; Joo JY
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):847-51. PubMed ID: 15145998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis.
    Gao P; Wang D; Zhao Z; Cai Y; Li T; Shi H; Wu W; He W; Yin L; Huang S; Zhu F; Jiao L; Ji X; Qureshi AI; Ling F
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1275-80. PubMed ID: 26869472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular treatment of symptomatic intracranial arterial stenosis: six-year experience in a single-center series of 42 consecutive patients with acute and mid-term results.
    Costalat V; Maldonado IL; Zerlauth JB; Menjot N; Riquelme C; Machi P; Vendrell JF; Bonafé A
    Neurosurgery; 2010 Dec; 67(6):1505-13; discussion 1513-4. PubMed ID: 21107181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitaire stents for the treatment of complex symptomatic intracranial stenosis after antithrombotic failure: safety and efficacy evaluation.
    Duan G; Feng Z; Zhang L; Zhang P; Chen L; Hong B; Xu Y; Zhao W; Liu J; Huang Q
    J Neurointerv Surg; 2016 Jul; 8(7):680-4. PubMed ID: 26041096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation.
    Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1487-1492. PubMed ID: 29976834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sole angioplasty with tiny balloon for high-risk complex symptomatic intracranial atherosclerotic stenosis].
    Qi P; Wang JJ; Wang LJ; Lu J; Hu S; Yang XM; Chen KP; Wang HF; Wang DM
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):458-463. PubMed ID: 29886671
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.
    Ueda T; Takaishi S; Yoshie T; Usuki N; Tatsuno K; Ohtsubo H; Araga T; Kaga Y; Takada T
    BMC Neurol; 2022 Dec; 22(1):477. PubMed ID: 36510182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience.
    de Rochemont Rdu M; Turowski B; Buchkremer M; Sitzer M; Zanella FE; Berkefeld J
    Radiology; 2004 Apr; 231(1):45-9. PubMed ID: 15068940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.